Q1 2025

Filed Oct 21, 2024 · 10-Q · 51 days after period end · 0001683168-24-007261

Q1 2025 · 10-Q

Revenue

$178.89K

+145.7% vs Q1 2024

Net Income

-$76.31K

N/M vs Q1 2024

EPS Diluted

-$0.00

N/M vs Q1 2024

Gross Profit$170,525+166.4%

Operating Income

Same quarter

Metric	Q1 2025	Q1 2024	Q1 2023	Q1 2012
Revenue	$178.89K	$72.82K	—	$17.29M
Net Income	-$76.31K	-$181.79K	-$212.03K	$3.10M
EPS Diluted	-$0.00	-$0.00	—	$0.24

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Cannabis Bioscience International Holdings, Inc. · CIK 1411057 · Engraved from SEC EDGAR